Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
KUAISHOU-W
01024
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net interest income | -13.38%14.34B | -0.30%32.96B | 2.73%16.56B | 20.68%33.06B | 32.79%16.12B | 9.14%27.39B | 0.70%12.14B | 5.03%25.1B | 0.35%12.06B | -5.91%23.9B |
| -Interest income | -13.38%14.34B | -0.30%32.96B | 2.73%16.56B | 20.68%33.06B | 32.79%16.12B | 9.14%27.39B | 0.70%12.14B | 5.03%25.1B | 0.35%12.06B | -5.91%23.9B |
| Net service income | 6.83%2.7B | 0.36%4.92B | -4.54%2.53B | -4.05%4.9B | 8.07%2.65B | -3.42%5.11B | -0.43%2.45B | 19.04%5.29B | 17.45%2.46B | 25.68%4.44B |
| -Service income | 6.83%2.7B | 0.36%4.92B | -4.54%2.53B | -4.05%4.9B | 8.07%2.65B | -3.42%5.11B | -0.43%2.45B | 19.04%5.29B | 17.45%2.46B | 25.68%4.44B |
| Securities and investments income | 183.27%720.41M | 106.00%595.81M | -1.76%254.32M | 33.44%289.23M | 65.43%258.88M | 38.27%216.75M | 98.64%156.49M | -51.39%156.76M | -75.19%78.78M | -30.57%322.49M |
| Special items of operating revenue | -1.70%15.84B | -7.73%34.48B | 7.63%16.11B | -20.83%37.38B | -45.98%14.97B | -29.41%47.21B | 4.50%27.72B | -3.95%66.88B | -12.16%26.52B | 5.71%69.63B |
| Operating revenue | -5.22%33.61B | -3.53%72.96B | 4.29%35.46B | -5.38%75.63B | -19.93%34B | -17.96%79.93B | 3.27%42.46B | -0.88%97.43B | -7.85%41.12B | 3.18%98.29B |
| Operating profit before deducting impairment | -5.22%33.61B | -3.53%72.96B | 4.29%35.46B | -5.38%75.63B | -19.93%34B | -17.96%79.93B | 3.27%42.46B | -0.88%97.43B | -7.85%41.12B | 3.18%98.29B |
| Impairment and provisions | -124.76%-11.04B | -10.06%-10.73B | -57.92%-4.91B | 26.46%-9.75B | 47.05%-3.11B | -13.09%-13.26B | -84.84%-5.88B | 16.84%-11.72B | 30.86%-3.18B | -57.96%-14.1B |
| -Impairment losses of other assets | -124.76%-11.04B | -10.06%-10.73B | -57.92%-4.91B | 26.46%-9.75B | 47.05%-3.11B | -13.09%-13.26B | -84.84%-5.88B | 16.84%-11.72B | 30.86%-3.18B | -57.96%-14.1B |
| Operating profit after deducting impairment | -26.13%22.56B | -5.54%62.23B | -1.12%30.54B | -1.19%65.88B | -15.57%30.89B | -22.21%66.67B | -3.57%36.59B | 1.79%85.7B | -5.21%37.94B | -2.49%84.19B |
| Operating expenses - after deducting impairment | 5.73%-2.71B | -0.03%-6.19B | 12.18%-2.88B | 7.50%-6.19B | -9.50%-3.28B | 4.53%-6.69B | 11.99%-2.99B | -3.74%-7.01B | -22.43%-3.4B | -2.72%-6.76B |
| -Employee compensation and benefits | 1.43%-2.49B | 3.22%-5.53B | 17.13%-2.52B | 6.74%-5.71B | -13.09%-3.05B | 4.31%-6.12B | 14.07%-2.69B | -3.89%-6.4B | -23.75%-3.13B | -2.62%-6.16B |
| Special items of operating profit | 9.23%-24.23B | 3.28%-56.54B | -1.77%-26.7B | 1.78%-58.46B | 8.65%-26.23B | 9.02%-59.52B | -6.30%-28.71B | -3.50%-65.41B | 6.07%-27.01B | -0.24%-63.2B |
| Operating profit | -552.27%-4.38B | -140.63%-500.67M | -29.77%969.17M | 166.15%1.23B | -71.71%1.38B | -96.51%463.03M | -35.17%4.88B | -6.70%13.28B | -11.32%7.53B | -14.82%14.23B |
| Net profit from sale of subsidiaries | 297.25%754.42M | -85.75%76.78M | -228.81%-382.47M | -49.13%538.65M | -76.18%296.92M | 248.30%1.06B | 341.61%1.25B | -83.50%303.99M | -76.42%282.27M | 108.97%1.84B |
| Share of profits of associates | -55.85%1.04B | -31.18%4.43B | -36.77%2.35B | -28.38%6.43B | 10.57%3.72B | 54.44%8.98B | 74.12%3.37B | 2,201.61%5.82B | 84.21%1.93B | -86.84%252.72M |
| Special items of earning before tax | 85.77%-941K | 25.29%-13.64M | 87.12%-6.61M | 61.57%-18.26M | 97.91%-51.35M | -135.88%-47.51M | -42,257.05%-2.46B | -13.06%-20.14M | 129.08%5.84M | 92.50%-17.82M |
| Earning before tax | -188.26%-2.59B | -51.26%3.99B | -45.14%2.93B | -21.72%8.19B | -23.93%5.35B | -46.04%10.46B | -27.86%7.03B | 18.82%19.38B | -9.01%9.75B | -15.38%16.31B |
| Tax | 1,356.72%3.5B | 59.59%-482.08M | 66.45%-278.13M | 63.03%-1.19B | 59.60%-828.91M | 49.42%-3.23B | 23.17%-2.05B | -19.81%-6.38B | 26.55%-2.67B | 7.48%-5.32B |
| After-tax profit from continuing operations | -65.93%905.18M | -49.84%3.51B | -41.23%2.66B | -3.29%6.99B | -9.23%4.52B | -44.38%7.23B | -29.62%4.98B | 18.34%13B | -0.00%7.08B | -18.74%10.99B |
| After-tax profit from no-continuing operations | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 150.07%3.75B |
| Earning After tax | -65.93%905.18M | -49.84%3.51B | -41.23%2.66B | -3.29%6.99B | -9.23%4.52B | -44.38%7.23B | -29.62%4.98B | -11.79%13B | -3.66%7.08B | -1.87%14.74B |
| Minority profit | -374.65%-1.38B | -59.76%471.84M | 10.55%500.78M | 27.75%1.17B | -4.08%452.97M | -2.22%917.86M | 21.25%472.25M | -36.97%938.75M | -61.24%389.49M | -24.21%1.49B |
| Profits attributable to shareholders | 5.78%2.28B | -47.84%3.04B | -47.00%2.16B | -7.80%5.82B | -9.77%4.07B | -47.66%6.31B | -32.59%4.51B | -8.95%12.06B | 5.47%6.69B | 1.49%13.25B |
| Basic earnings per share | 25.00%0.05 | -63.64%0.04 | -55.56%0.04 | -21.43%0.11 | -25.00%0.09 | -51.72%0.14 | -20.00%0.12 | -9.38%0.29 | -11.76%0.15 | 3.23%0.32 |
| Diluted earnings per share | 25.00%0.05 | -63.64%0.04 | -55.56%0.04 | -21.43%0.11 | -25.00%0.09 | -51.72%0.14 | -20.00%0.12 | -9.38%0.29 | -11.76%0.15 | 3.23%0.32 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | PwC, PwC Zhongtian Certified Public Accountants (Special General Partnership) | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.